Hyperphosphatemia (High Phosphate): Itching

For people on dialysis or living with advanced kidney disease, relentless itching — doctors call it chronic kidney disease–associated pruritus — can be one of the most miserable and least talked-about parts of the illness. It often has no rash to explain it, can keep people awake night after night, and is strongly linked to a high blood phosphate level (hyperphosphatemia) and the wider mineral imbalance of failing kidneys. The honest picture matters here: itching has countless ordinary causes that have nothing to do with phosphate, and even in kidney disease the link to phosphate is a real but partial one — lowering phosphate helps some people and not others. This page explains what kidney-related itch feels like, the leading ideas about why it happens, the many other things that cause itching, the clues that point toward the kidneys and phosphate, and the treatments that genuinely help.

Table of Contents

1. What Kidney-Related Itching Feels Like
2. The Mechanism: Why High Phosphate and Failing Kidneys Cause Itch
3. An Honest Caveat: Itching Has Many Causes
4. Clues That Point Toward the Kidneys and Phosphate
5. Why Phosphate Climbs in Kidney Disease
6. Getting Checked
7. How the Itch Is Treated
8. When to Seek Care / Red Flags
9. Key Research Papers
10. Connections
11. Featured Videos

What Kidney-Related Itching Feels Like

The itch of advanced kidney disease has a character that sets it apart from a bug bite or a patch of dry skin, and recognizing that character is the first step to getting it taken seriously. People who live with it describe a deep, maddening itch that the fingernails never quite reach — and, tellingly, there is usually nothing to see. The skin may look entirely normal, or show only the scratch marks the itching itself has caused.

The typical pattern looks like this:

• Often no rash. Unlike eczema, hives, or an allergic reaction, kidney-related itch frequently leaves the skin looking unremarkable. When marks do appear, they are usually the consequence of scratching — scratches, scabs, thickened leathery patches, or small firm nodules — rather than a primary rash.
• Widespread, but with favorite spots. It can affect the whole body, but the back, arms, head, and abdomen are commonly the worst. In some people it is generalized; in others it migrates from place to place.
• Worse at night and after dialysis. Many people find it flares in the evening and overnight, wrecking sleep, and some notice it intensifies during or just after a hemodialysis session. Heat, sweating, and dry skin tend to make it worse.
• Persistent and demoralizing. This is not a fleeting itch. At its worst it is daily and unrelenting, and the lost sleep, anxiety, and low mood that follow are well documented — severe itch in dialysis patients has been linked to poorer quality of life and worse outcomes overall.

One thing that distinguishes this symptom from most others covered in this Toxicity hub is that itching is something the body's own nerves and immune system generate, rather than a direct mechanical effect of the mineral. So while it travels with high phosphate, it is a more indirect and individual symptom than, say, the calcium and bone problems or the vascular calcification that the same mineral imbalance drives. Those siblings explain the structural damage; this page explains the suffering you can feel but not see.

Back to Table of Contents

The Mechanism: Why High Phosphate and Failing Kidneys Cause Itch

The honest scientific position is that the exact cause of kidney-related itch is not fully understood, and it is almost certainly not one single thing. The best current evidence points to several overlapping problems that build up when the kidneys can no longer keep the blood clean, with high phosphate as one important thread. Two ideas dominate.

1. Mineral overload and skin deposits. Healthy kidneys excrete the phosphate we eat. When they fail, phosphate accumulates in the blood. The body responds by releasing parathyroid hormone, which pulls calcium out of bone, so calcium and phosphate both run high together. When the product of calcium and phosphate rises, microscopic calcium-phosphate crystals can precipitate in the skin and irritate the nerve endings there. This is the most intuitive link to phosphate, and observational studies in dialysis patients have repeatedly found that those with higher serum phosphorus and a higher calcium×phosphate product report more severe itching. It is an association, not absolute proof of cause — but it is consistent and biologically plausible.

2. The body's natural opioid system goes out of balance. Your skin and nervous system carry receptors for the body's own opioid-like molecules, and these come in two main flavors that pull in opposite directions: mu receptors tend to promote itch, while kappa receptors tend to suppress it. In kidney failure this seesaw appears to tip — relatively too much mu activity, too little kappa — so the itch signal is amplified. This is not a fringe theory: it is the reason a drug that deliberately stimulates kappa receptors (difelikefalin, discussed below) was developed and proven to reduce kidney itch in large trials.

An analogy. Think of itch as a fire alarm wired into your skin. In kidney disease, two things go wrong at once. First, the air fills with irritant smoke — the retained phosphate, calcium-phosphate crystals, and the broader soup of waste products and low-grade inflammation that build up when the kidneys stop filtering. Second, the alarm's own sensitivity dial gets turned up because the opioid “volume control” is out of balance. The result is an alarm that blares loudly at smoke that a healthy body would have quietly cleared and largely ignored. Lowering phosphate is like clearing some of the smoke; the newer kappa-targeting drugs work on the volume dial. That is exactly why no single treatment fixes everyone — different people have more of one problem than the other.

Alongside these two leading ideas, researchers also implicate systemic inflammation (kidney failure is a pro-inflammatory state, and itch is partly an immune phenomenon), dry skin (extremely common in dialysis patients and a powerful itch amplifier on its own), peripheral nerve changes from uremia, and a build-up of other poorly-cleared waste molecules. Phosphate is one piece of a larger puzzle — an important and, crucially, a modifiable piece.

Back to Table of Contents

An Honest Caveat: Itching Has Many Causes

It would be misleading to suggest that itching means high phosphate. Itching is one of the most common symptoms in all of medicine, and the overwhelming majority of itching has nothing whatever to do with phosphate or the kidneys. Before pinning an itch on mineral imbalance, it is worth remembering how long the ordinary list is:

• Skin conditions. Dry skin (by far the most common cause), eczema, psoriasis, hives, contact allergy to soaps or detergents, fungal infections, and scabies. These usually — though not always — come with a visible rash.
• Allergy and irritation. Reactions to medications, foods, plants, insect bites, or new skincare products.
• Other internal causes. Liver disease and bile duct blockage (where bile salts build up), thyroid disease, iron deficiency, diabetes, and certain blood disorders and cancers (such as lymphoma) can all cause generalized itch — sometimes with no rash, just like kidney itch.
• Medications. Opioid painkillers are a classic cause of itch (a direct demonstration of the mu-receptor effect described above), and many other drugs can do it.
• Nerve and psychological causes. Pinched nerves, shingles, and the itch that anxiety, stress, and habit can amplify.

This honesty cuts in a practical direction. If you have healthy kidneys and you are itching, high phosphate is almost certainly not the explanation — people with normal kidney function clear phosphate efficiently and essentially never develop hyperphosphatemia from food. The phosphate-and-itch story is overwhelmingly a story about advanced kidney disease and dialysis. So the right question is rarely “is my itch caused by phosphate?” in isolation; it is “I have kidney disease and I'm itching — how much of this is the kidneys, and what will help?”

Back to Table of Contents

Clues That Point Toward the Kidneys and Phosphate

Given how many causes itching has, what makes a clinician suspect kidney-related pruritus rather than something more ordinary? Several features, taken together, raise the index of suspicion:

• Known advanced kidney disease or dialysis. This is the single biggest clue. Chronic kidney disease–associated pruritus is common in people on hemodialysis — international surveys have found that roughly four in ten dialysis patients are affected to some degree, and a substantial minority severely. It is uncommon in early kidney disease and rises as kidney function falls.
• Generalized itch with little or no rash. An itch all over the body with normal-looking skin (aside from scratch marks) fits the kidney pattern far better than a localized, rashy itch.
• A high phosphate level on bloodwork. When the lab shows an elevated serum phosphorus — and often a raised calcium×phosphate product or high parathyroid hormone alongside it — the mineral imbalance becomes a plausible contributor. Studies have linked higher phosphorus to more severe itch, though many patients with high phosphate do not itch and some who itch have near-normal phosphate, so the number is a clue, not a verdict.
• Worse after dialysis, worse at night. A flare timed to dialysis sessions or to the evening fits the recognized pattern.
• Other ordinary causes ruled out. When dry skin has been treated, no rash or scabies is found, and liver, thyroid, and iron tests are unremarkable, the kidney explanation becomes more likely by elimination.

The mineral imbalance that drives the itch is the same one behind the other two pages in this hub. If your itch tracks with high phosphate, you are very likely also being monitored for the bone changes covered in Calcium & Bone Problems and the blood-vessel hardening in Vascular Calcification — controlling phosphate is the shared thread that helps all three.

Back to Table of Contents

Why Phosphate Climbs in Kidney Disease

Because the itch is downstream of high phosphate, it helps to understand why phosphate rises in the first place — and why it is so hard to control. The kidneys are the body's main route for getting rid of the phosphate we eat. As kidney function declines, that disposal route narrows, and phosphate begins to accumulate. The main contributors are:

• Reduced kidney clearance. This is the root cause. In advanced chronic kidney disease, and especially once a person is on dialysis, the kidneys can no longer excrete the daily phosphate load, so it builds up between dialysis sessions.
• Dietary phosphate — and hidden additives. Phosphate is abundant in protein-rich foods (dairy, meat, nuts, legumes), but the bigger problem for many patients is inorganic phosphate additives used as preservatives in processed foods, fast food, colas, and many packaged products. This additive phosphate is absorbed far more completely than the phosphate naturally bound in whole foods, so a diet heavy in processed food can push phosphate up sharply — often invisibly, because additives are not always clearly labeled.
• The parathyroid response. Rising phosphate, together with the low vitamin D and low calcium of kidney disease, drives the parathyroid glands to overproduce parathyroid hormone (secondary hyperparathyroidism). That hormone pulls calcium and yet more phosphate out of bone, worsening the mineral overload and feeding the cycle.
• Dialysis only removes so much. A standard hemodialysis session clears a limited amount of phosphate, and the body can re-accumulate it between sessions. This is why diet and phosphate-binding medication remain essential even for people on dialysis.

This web of causes is collectively known as chronic kidney disease–mineral and bone disorder (CKD-MBD) — the disturbance of calcium, phosphate, parathyroid hormone, and vitamin D that comes with failing kidneys. Itching is one of its more visible-to-the-patient consequences, even though the deeper damage is to bones and blood vessels.

Back to Table of Contents

Getting Checked

There is no single test that says “this itch is from your kidneys.” The diagnosis is made by combining the clinical picture with bloodwork and by ruling out other causes. The steps are usually:

A description of the itch. When it started, where it is, whether there is a rash, what makes it better or worse, and how it relates to dialysis. Clinicians often grade its severity (for example, with a simple 0–10 scale) so that response to treatment can be tracked over time.

Bloodwork for minerals and kidney function. A Comprehensive Metabolic Panel reports kidney function (creatinine) and calcium, and a serum phosphorus level is checked alongside it — together with parathyroid hormone (PTH) and often vitamin D. These numbers reveal how well the mineral imbalance of CKD-MBD is being controlled and whether high phosphate is a plausible driver of the itch. For people on dialysis, these levels are typically monitored regularly anyway.

Ruling out the common mimics. Because the ordinary causes of itch are so common, a clinician will look for and treat dry skin, check for rashes, scabies, or fungal infection, and — when the picture is unclear — run tests for liver disease, thyroid problems, and iron deficiency. A skin examination is part of the assessment precisely because kidney itch usually shows no primary rash, so a rash points elsewhere.

Back to Table of Contents

How the Itch Is Treated

The good news is that kidney-related itch is treatable, and the options have improved markedly in recent years. Because the cause is multi-layered, treatment is usually layered too — it works best as a stepwise plan, not a single magic bullet. The general order is: get the basics right, control phosphate, then add targeted medication if needed.

• Treat dry skin first. Liberal, frequent use of fragrance-free emollients (moisturizers), lukewarm rather than hot showers, gentle soaps, and a humidified bedroom address one of the most common and most fixable amplifiers of itch. For some people this alone makes a meaningful difference, and it costs almost nothing.
• Control phosphate and the mineral balance. Because high phosphate is a modifiable contributor, getting it into target range is a cornerstone. That means a phosphate-aware diet — in particular cutting inorganic phosphate additives in processed foods, fast food, and colas — taking phosphate-binder medication with meals (these trap dietary phosphate in the gut so it is not absorbed), and adequate dialysis. Managing parathyroid hormone and vitamin D is part of the same effort. Lowering phosphate does not relieve everyone's itch, but it is worth doing in its own right because it also protects bones and blood vessels.
• Difelikefalin (Korsuva). This is a genuinely important advance and the first drug developed and approved specifically for moderate-to-severe kidney itch in hemodialysis patients. It works on the opioid imbalance described earlier — it stimulates kappa opioid receptors to dampen the itch signal — and it is given intravenously at the end of a dialysis session. In large randomized trials (the KALM studies), it significantly reduced itch intensity compared with placebo, with the main side effects being mild dizziness, diarrhea, or nausea.
• Gabapentin or pregabalin. These nerve-calming medications, given at low and carefully reduced doses because the kidneys clear them poorly, have reduced uremic itch in randomized trials and are a widely used option. Drowsiness and dizziness are the usual limiting side effects, so dosing must be cautious in dialysis patients.
• Other measures. Antihistamines are often tried but generally work poorly for kidney itch (it is not primarily a histamine problem), although a sedating one may help sleep. Ultraviolet B (UVB) phototherapy helps some people, and in the right candidate a successful kidney transplant typically resolves the itch entirely, because it restores the kidney function that caused the problem.

The practical message for a patient is one of hope tempered with patience: this symptom is real, it is recognized, and there are now effective treatments — but finding the right combination can take some trial and adjustment with your kidney team. Itch that is wrecking your sleep is worth raising explicitly, because it is often under-reported and therefore under-treated.

Back to Table of Contents

When to Seek Care / Red Flags

Itching itself is rarely an emergency, but certain situations mean you should be seen promptly rather than enduring it — or could signal a problem beyond the kidneys:

• Itch that is destroying your sleep or quality of life. This alone is a reason to seek treatment, not to suffer in silence. Severe, persistent itch in kidney disease is treatable and should be raised with your kidney team.
• Skin that is broken, weeping, crusted, red, warm, or painful. Constant scratching can break the skin and lead to infection — spreading redness, warmth, pus, or fever needs prompt medical attention, especially for someone on dialysis whose infection risk is higher.
• New, generalized itch in someone without known kidney disease. Because itch with no rash can be a sign of liver disease, thyroid problems, iron deficiency, or (less often) a blood cancer such as lymphoma, a new unexplained whole-body itch deserves a medical evaluation to find the cause — it should not be assumed to be “just dry skin.”
• Itch with yellowing of the skin or eyes, dark urine, or pale stools. This combination points toward the liver or bile ducts and should be evaluated — see jaundice and liver disease.
• Itch with unexplained weight loss, night sweats, or swollen glands. These “B symptoms” alongside generalized itch warrant prompt assessment to exclude an underlying systemic illness.

For the person already on dialysis, the most useful thing to do is simple: tell your nephrology team how bad the itch is and how much it affects your sleep. It is one of the most under-reported symptoms in kidney care, and naming it is what opens the door to the treatments above.

Back to Table of Contents

Key Research Papers

1. Pisoni RL, Wikström B, Elder SJ, et al. (2006). Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrology Dialysis Transplantation;21(12):3495-3505. — DOI: 10.1093/ndt/gfl461
2. Rayner HC, Larkina M, Wang M, et al. (2017). International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis. Clinical Journal of the American Society of Nephrology;12(12):2000-2007. — DOI: 10.2215/CJN.03280317
3. Narita I, Alchi B, Omori K, et al. (2006). Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney International;69(9):1626-1632. — DOI: 10.1038/sj.ki.5000251
4. Mettang T, Kremer AE (2015). Uremic pruritus. Kidney International;87(4):685-691. — DOI: 10.1038/ki.2013.454
5. Verduzco HA, Shirazian S (2020). CKD-Associated Pruritus: New Insights Into Diagnosis, Pathogenesis, and Management. Kidney International Reports;5(9):1387-1402. — DOI: 10.1016/j.ekir.2020.04.027
6. Wikström B, Gellert R, Ladefoged SD, et al. (2005). κ-Opioid System in Uremic Pruritus: Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Studies. Journal of the American Society of Nephrology;16(12):3742-3747. — DOI: 10.1681/ASN.2005020152
7. Fishbane S, Jamal A, Munera C, et al. (2020). A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus. New England Journal of Medicine;382(3):222-232. — DOI: 10.1056/NEJMoa1912770
8. Topf J, Wooldridge T, McCafferty K, et al. (2022). Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies. Kidney Medicine;4(8):100512. — DOI: 10.1016/j.xkme.2022.100512
9. Gunal AI, Ozalp G, Yoldas TK, et al. (2004). Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrology Dialysis Transplantation;19(12):3137-3139. — DOI: 10.1093/ndt/gfh496
10. Simonsen E, Komenda P, Lerner B, et al. (2017). Treatment of Uremic Pruritus: A Systematic Review. American Journal of Kidney Diseases;70(5):638-655. — DOI: 10.1053/j.ajkd.2017.05.018
11. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group (2017). KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Kidney International Supplements;7(1):1-59. — DOI: 10.1016/j.kisu.2017.04.001
12. Kalantar-Zadeh K, Gutekunst L, Mehrotra R, et al. (2010). Understanding Sources of Dietary Phosphorus in the Treatment of Patients with Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology;5(3):519-530. — DOI: 10.2215/CJN.06080809

PubMed Topic Searches

• PubMed — Chronic kidney disease–associated pruritus
• PubMed — Uremic pruritus and serum phosphorus / calcium-phosphate
• PubMed — Difelikefalin for hemodialysis pruritus
• PubMed — Gabapentin / pregabalin for uremic pruritus
• PubMed — CKD-MBD and phosphate management (KDIGO)

Back to Table of Contents

Connections

• Hyperphosphatemia Symptom Hub
• Hyperphosphatemia and Calcium & Bone Problems
• Hyperphosphatemia and Vascular Calcification
• Phosphorus Deficiency Symptom Hub
• Phosphorus Overview
• Phosphorus and Bone Mineralization
• Calcium
• Magnesium
• Chronic Kidney Disease
• Liver Disease
• Hyperparathyroidism
• Jaundice
• Comprehensive Metabolic Panel

Back to Table of Contents

Featured Videos

×